Pfenex Expression Technology™ COMMERCIAL LICENSE AGREEMENTLicense Agreement • April 2nd, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Delaware
This Agreement is effective as of the latest date of signing below and is by and between Dow Global Technologies Incorporated ("Dow"), a Delaware corporation having its principal offices at 2030 Dow Center, Midland, MI, 48674 USA and VGX Pharmaceuticals, Inc, a Delaware corporation ("VGX") having a principal place of business at 450 Sentry Parkway, Blue Bell, PA 19422.
